Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $25.7200 (-5.51%) ($25.4400 - $27.4100) on Wed. Apr. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.38% (three month average) | RSI | 64 | Latest Price | $25.7200(-5.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.5% a day on average for past five trading days. | Weekly Trend | EDIT advances 1.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(60%) XBI(59%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.19% in a week (0% probabilities). VXX(-12%) VIXM(-8%) TLT(-4%) IFRA(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.19% (StdDev 4.38%) | Hourly BBV | 0 () | Intraday Trend | -5.9% | | | |
|
5 Day Moving Average | $26.21(-1.87%) | 10 Day Moving Average | $26.66(-3.53%) | 20 Day Moving Average | $25.51(0.82%) | To recent high | -7% | To recent low | 32.4% | Market Cap | $1.597b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |